|
|
|||
|
|
||
|
|||
|
High–Definition Cellular Analysis Revolutionizes Blood Testing in Hospital Labs ORANGE COUNTY, Calif. (January 8, 2009) – Beckman Coulter, Inc. ushers in a new era of cellular analysis with the release of the UniCel® DxH 800 Coulter® Cellular Analysis System, for mid-to-high volume laboratories. The new instrument features advanced technologies, including high-definition signal processing and multi-angle light scatter, which produce ten times more data than traditional hematology analyzers. Moving parts are minimized to increase instrument reliability and technologist safety. The DxH 800's modular design and small footprint make it the ultimate scalable solution for the LEAN lab. "The UniCel DxH 800 will transform the hematology lab with unparalleled quality of results, innovative efficiency solutions and revolutionary scalability, reinforcing Beckman Coulter's place at the forefront of cellular analysis." said Cynthia Collins, group vice president of Cellular Analysis at Beckman Coulter. The UniCel DxH 800 begins where the LH 700 series left off, with a clear focus toward improving patient care. Like the LH series, Decision Rules are a notable factor in the analyzer's success, only the UniCel DxH 800 takes decision criteria to the next level by reducing the need for manual review and eliminating the need for manual intervention during repeat or reflex testing. Directed by innovative software, samples are automatically pulled back to the aspirator without operator intervention. The UniCel DxH 800 is built with a host of revolutionary and proprietary technologies that will improve efficiencies and significantly reduce the need for manual intervention; resolving issues that continue to vex traditional hematology processes. For example, the Specimen Transport Module (STM) allows samples to move through the analyzer by magnetic force without the need for a track or additional software. It is configured with no exposed moving parts and aids in making the UniCel DxH 800 one of the most reliable and safest hematology instruments available. Leveraging Beckman Coulter's expertise in Routine Hematology, Flow Cytometry, Chemistry, Immunoassay and Automation, the UniCel® DxH 800 Coulter® Cellular Analysis System is the newest member of the UniCel family of laboratory solutions. Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company's 2007 annual revenue of $2.76 billion. For more information, visit www.beckmancoulter.com.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Back to Press Releases 
